Abstract
Approximately 200,000 men will be diagnosed with prostate cancer in 1994. While localized disease is potentially curable with surgery or radiation therapy, metastatic disease is incurable. The most frequent site of metastasis is bone. Spinal cord compression occurs in approximately 7% of men with prostate cancer. Back pain often heralds the diagnosis of spinal cord compression. In prostate cancer patients with back pain or signs of myelopathy or radiculopathy, plain radiographs of the spine and magnetic resonance imaging should be performed. Early diagnosis is of utmost importance. The neurologic status prior to treatment is the major determinant influencing outcome. Following diagnosis, corticosteroid therapy should begin immediately. Hormonal therapy should be instituted in those patients who have not previously undergone hormonal manipulation. The standard approach to definitive therapy is radiation. Surgical decompression plays a role in patients with severe myelopathy, spinal instability, and in those patients whose neurologic status deteriorates during or after radiation therapy.
Similar content being viewed by others
References
American Cancer Society: Cancer Facts & Figures — 1994. Atlanta, American Cancer Society, 1994
Constans JP, de Devitiis E, Donzelli R, Spaziante R, Meder JF, Haye C: Spinal metastasis with neurological manifestations. J Neurosurg 59: 111–118, 1983
Sorensen PS, Borgesen SE, Rohde K, Rasmusson B, Bach F, Boge-Rasmussen T, Stjernholm P, Larsen BH, Agerlin N, Gjerris F: Metastatic epidural spinal cord compression: Results of treatment and survival. Cancer 65: 1502–1508, 1990
Gilbert RW, Kim JH, Posner JB: Epidural spinal cord compression from metastatic tumor: Diagnosis and treatment. Ann Neurol 3: 40–51, 1978
Greenberg HS, Kim JH, Posner JB: Epidural spinal cord compression from metastatic tumor: Results from a new protocol. Ann Neurol 8: 361–366, 1980
Kuban DA, El-Mahdi AM, Sigfred SV, Schellhammer PF, Babb TJ: Characteristics of spinal cord compression in adenocarcinoma of prostate. Urology 28: 364–369, 1986
Smith EM, Hampel N, Ruff RL, Bodner DR, Resnick MI: Spinal cord compression secondary to prostate carcinoma: Treatment and prognosis. J Urol 149: 330–333, 1993
Jacobs SC: Spread of prostatic cancer to bone. Urology 21: 337–344, 1983
Galasko CSB: The anatomy and pathways of skeletal metastases. In: Weiss L, Gilbert HA (eds) Bone Metastasis. Boston: G.K. Hall, 1981, pp 49–63
Mundy GR, Spiro TP: The mechanism of bone metastasis and bone destruction by tumor cells. In: Weiss L, Gilbert HA (eds) Bone Metastasis, Boston: G.K. Hall, p 64
Chackal-Roy M, Neimeyer C, Moore M, Zetter BR: Stimulation of human prostatic carcinoma cell growth by factors present in human bone marrow. J Clin Invest 84: 43–50, 1989
Haq M, Goltzman D, Tremblay G, Brodt P: Rat prostate adenocarcinoma cells disseminate to bone and adhere preferentially to bone marrow-derived endothelial cells. Cancer Research 52: 4613–4619, 1992
Auerbach R, Lu WC, Pardon E, Gumkowsky F, Kaminska G: Specificity of adhesion between murine tumor cells and capillary endothelium: anin vitro correlate of preferential metastasisin vivo. Cancer Research 47: 1492–1496, 1987
Kincade PW, Lee G, Pietrangeli CE, Hayashi SI, Gimble M: Cells and molecules that regulate B lymphopoiesis in bone marrow. Annual Rev Immunol 7: 111–143, 1989
Wu H-C, Hsieh J-T, Gleave ME, Brown NM, Pathak S, Chung LWK: Derivation of androgen-independent human LNCaP prostatic cancer cell sublines: role of bone stromal cells. Int J Cancer 57: 406–412, 1994
Chung LWK: Implications of stromal-epithelial interaction in human prostate cancer growth, progession and differentiation. Seminars in cancer biology, 4: 138–192, 1993
McKeehan WL, Adams PS: Heparin-binding growth factor prostatropin attentuates inhibition of rat prostate tumors epithelial cell growth by transforming growth factor type beta.In vitro Cell Dev Biol 24: 243–246, 1988
Perkel VS, Subburanman M, Baylind DJ, Linkhart TA: An inhibitory insulin-like growth factor binding protein (IN-IGFBP) from human prostate cell conditioned medium reveals N-terminal sequence identity with bone-derived IN-IGFBP. J Clin Endoc and Metab 71: 533–535, 1990
Gleave ME, Hsich JT, von Eschenbach AC, Chung LWK: Prostate and bone fibroblasts induce human prostate cancer growthin vivo: implications for bidirectional tumor-stromal cell interactions in prostate carcinoma growth and metastasis. J Urol 147: 1151–1159, 1992
Sullivan LM, Quigley JP: An anticatalytic monoclonal antibody to avian plasminogen activator: its effect on the behavior of RSV-transformed chick fibroblasts. Cell 45: 905–915, 1986
Kirchheimer JC, Wojta J, Christ G, Binder BR: Proliferation of a human epidermal tumor cell line stimulated by urokinase. FASEB J 1: 125–128, 1987
Goltzman D, Bolivar I, Moroz LA, Rabbani SA: Urokinase and the mechanism of osteoblastic metastases by prostate cancer. Fibrinolysis 6: 63–69, 1992
Kirchheminer JC, Koller A, Binder BR: Isolation and characterization of plasminogen activators from hyperplastic and malignant prostate tissue. Biochem Biophys Acta 797: 256–265, 1984
Kirchheimer JC, Pfluger H, Ritschl P, Hichert G, Binder BR: Plasminogen activator activity in bone metastases of prostatic carcinomas as compared to primary tumors. Invasion metastasis 5: 344–355, 1985
Gaylis FD, Keer HN, Wilson MJ, Kwaan HC, Sinha AA, Kozlowski JM: Plasminogen activators in human prostate cancer cell lines and tumors: correlation with the aggressive phenotype. J Urology 142: 193–198, 1989
Sadasivan R, Van Veldhuizen P, Horrat B, Dwyer T, Kimura M, Austenfeld M, Garcia F: Deletions of the gene for plasminogen activators uPA and tPA in human prostate carcinoma. Cancer Research 34: 194, 1993
Hollas W, Hoosein N, Chung LWK, Mazar A, Henkin J, Kariko K, Barnathan ES, Boyd D: Expression of urokinase and its receptor in invasive an non-invasive prostate cancer cell lines. Thrombosis and Haemostasis 68: 662–666, 1992
Hoosein NM, Boyd DD, Hollas WJ, Mazar A, Henkin J, Chung LWK: Involvement of urokinase and its receptor in the invasiveness of human prostatic carcinoma cell lines. Cancer Communications 3: 255–264, 1991
Achbarou A, Kaiser S, Tremblay G, Ste-Marie L-G, Brodt P, Goltzman D, Rabbani SA: Urokinase overproduction results in increased skeletal metastases by prostate cancer cellsin vivo. Cancer Research 54: 2372–2377, 1994
Getzenberg RH, Coffey DS: Tissue specificity of the hormonal response in sex accessory tissues is associated with nuclear matrix protein patterns. Mol Endo 4: 1336–1342, 1990
Getzenberg RH: The nuclear matrix and the regulation of gene expression: tissue specificity. J Cell Biochem 55: 22–31, 1994
Getzenberg RH, Pienta KJ, Huang EYW, Coffey DS: Identification of nuclear matrix proteins in the cancer and normal rat prostate. Cancer Res 51: 6514–6520, 1991
Partin AW, Getzenberg RH, CarMichael MJ, Vindivich D, Yoo J, Epstein JI, Coffey DS: Nuclear matrix protein patterns in human benign prostatic hyperplasia and prostate cancer. Cancer Res 53: 744–746, 1993
Stark RJ, Henson RA, Evans SJW: Spinal metastasis: a retrospective survey from a general hospital. Brain 105: 189–213, 1982
Byrne TN: Spinal cord compression from epidural metastasis. New Eng J Med 327: 614–619, 1992
Shoskes DA, Perrin RG: The role of surgical management for symptomatic spinal cord compression in patients with metastatic prostate cancer. J Urol 142: 337–339, 1989
Zelefsky MJ, Scher HI, Krol G, Portenoy RK, Leibel SA, Fuks ZY: Spinal epidural tumor in patients with prostate cancer. Cancer 70: 2319–2325, 1992
Rosenthal MA, Rosen D, Raghavan D, Leicester J, Duval P, Bessor M, Pearson B: Spinal cord compression in prostate cancer: A 10 year experience. B J Urol 69: 530–533, 1992
Flynn DF, Shipley WU: Management of spinal cord compression secondary to metastatic prostate carcinoma. Urol Clin N Amer 18: 145–152, 1989
Harrington KD: Anterior cord decompression and spinal stabilization for patients with metastatic lesions of the spine. J Neurosurg 61: 107–117, 1984
Rodichok LD, Harper GR, Ruckdeschel JC, Price A, Roberson G, Barron KD, Horton J: Early diagnosis of spinal epidural metastases. Am J Med 70: 1181–1188, 1981
Portenoy RK, Galer BS, Salamon O, Freilich M, Finkel JE, Milstein D, Thaler HT, Berger M, Lipton RB: Identification of epidural neoplasm: radiography and bone scintigraphy in the symptomatic and asymptomatic spine. Cancer 64: 2207–2213, 1989
Graus F, Krol G, Foley K: Early diagnosis of spinal cord epidural metastasis: Correlation of clinical and radiologic findings. Proc Am Soc Clin Oncol 4: 269, 1985 (abstract)
Carmody RF, Yang PJ, Seeley GW, Seeger JF, Unger EC, Johnson JE: Spinal cord compression due to metastatic disease: Diagnosis with MR imaging versus myelography. Radiology 173: 225–229, 1989
Bonner JA, Lichter AS: A caution about the use of MRI to diagnose spinal cord compression. New Eng J Med 332: 556–557, 1990
Ushio Y, Posner R, Posner JB, Shapiro WR: Experimental spinal cord compression by epidural neoplasms. Neurology 27: 422–429, 1977
Ushio Y, Posner R, Kim JH, Shapiro WR, Posner JB: Treatment of experimental spinal cord compression caused by extradural neoplasms. J Neurosurg 47: 380–390, 1977
Vecht CJ, Haaxma-Reiche H, van Putten WLJ, de Visser M, Vries EP, Twijnstra A: Initial bolus of conventional versus high dose dexamethasone in spinal cord compression. Neurology 39: 1255–1257, 1989
Iacovou JW, Marks JC, Abrams PH, Gingell JC, Ball AJ: Cord compression and carcinoma of the prostate: Is laminectomy justified? B J Urol 57: 733–736, 1985
Young RF, Post EM, King GA: Treatment of spinal epidural metastasis: Randomized prospective comparison of laminectomy and radiotherapy. J Neurosurg 53: 741–748, 1980
Tang SG, Byfield JE, Sharp TR, Utley JF, Quinol L, Seagren SL: Prognostic factors in the management of metastatic epidural spinal cord compression. J Neuro-oncol 1: 21–28, 1983
Kaminski HJ, Diwan VG, Ruff RL: Second occurrence of spinal epidural metastasis. Neurology 41: 744–746, 1991
Sundaresan N, Galicich JH, Lane JM, Bains MS, McCormack P: Treatment of neoplastic epidural cord compression by vertebral body resection and stabilization. J Neurosurg 63: 676–684, 1985
Siegal T, Siegal T, Robin G, Lubetski-Korn I, Fuks Z: Anterior decompression of the spine for metastatic epidural cord compression: A promising avenue of therapy. Ann Neurol 11: 28–34, 1982
Siegal T, Tiqva P, Siegal T: Vertebral body resection for epidural compression by malignant tumors: Results of forty-seven consecutive operative procedures. J Bone and Joint Surg 61-A: 375–382, 1985
Sundaresan N, Digiacinto GV, Hughes JEO, Cafferty M, Vallejo A: Treatment of neoplastic spinal cord compression: Results of a prospective study. Neurosurgery 29: 645–650, 1991
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Osborn, J.L., Getzenberg, R.H. & Trump, D.L. Spinal cord compression in prostate cancer. J Neuro-Oncol 23, 135–147 (1995). https://doi.org/10.1007/BF01053418
Issue Date:
DOI: https://doi.org/10.1007/BF01053418